ISCO, Springer to collaborate to publish Cellular Oncology journal

NewsGuard 100/100 Score

Springer and the International Society of Cellular Oncology (ISCO) will collaborate to publish Cellular Oncology starting this year. Cellular Oncology is the official journal of ISCO and publishes original papers and reviews on the latest advances in cancer research. It was previously published by IOS Press.

Cellular Oncology publishes scientific contributions from biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area and clinical applications. A major goal of the journal is to translate the latest developments from the research laboratory into routine patient management. Cellular Oncology thus provides a platform of scientific exchange between molecular biologists and geneticists, technical developers, pathologists, oncologists and other clinicians involved in the management of cancer patients.

Cellular Oncology will be available electronically, and in print, on www.springerlink.com, and six issues per year will be published. Features include Online First-, Cross Reference Linking, Electronic Supplementary Material and Alert services.

Professor Gerrit Meijer of the VU University Medical Center in Amsterdam, the Editor-in-Chief of the journal said: "That Cellular Oncology is now being published by one of the top-ranking publishers is excellent news for the authors who will now reach a much wider community of scientists as well as for an expanded readership, that may not have had access to the journal before. For the editorial team this is an exciting development since wider exposure and the publisher's professional approach provide excellent opportunities for achieving the ambitious goals of Cellular Oncology."

Evelin Schr-ck, President of the ISCO, said: "The International Society for Cellular Oncology aims to provide excellent communication platforms for scientists working in the field of biomedical oncology research. That the journal of the society now will be published by Springer strengthens this objective. ISCO looks forward to a fruitful and long-lasting collaboration with Springer."

Peter Butler, Editorial Director at Springer, said: "We are delighted to be partnering with the ISCO to publish such a highly-ranked journal. We look forward to working with Professor Meijer and his Editorial team to further develop Cellular Oncology, bringing the journal to as wide an audience as possible".

The International Society of Cellular Oncology aims to advance science in investigative and diagnostic cell pathology in cancer and other diseases. ISCO's mission is to provide a forum to share research, technologies and ideas; to promote collaboration between researchers worldwide; and to provide education on the latest advances in the field.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Largest study of BRCA1 and BRCA2 carriers refines cancer risk estimates in Asian population